<p>The percentage of <i>naïve</i> CD8+ T cells (CD45RA+CCR7+) (A), <i>central memory</i> (CD45RA−CCR7+) (B), <i>effector memory</i> (CD45RA−CCR7−) (C) and <i>effector</i> cells (CD45RA+CCR7−) (D) were compared in the groups. Higher levels of <i>naïve</i> CD8+ T-cells were observed in ASCT recipients compared to HIV+ patients. Whereas in HIV positive patients <i>effector memory</i> CD8+ T cells were the predominant memory phenotype, in ASCT recipients significantly higher levels of CD45RA+CCR7− <i>effector</i> CD8+ cells were evidenced. Each central bar represents the median value and each box corresponds to the 25<sup>th</sup> through 75<sup>th</sup> percentile (interquartile) range.</p
BACKGROUND: Reduced CD4 T lymphocytes counts can be observed in HIV infection and in patients underg...
<p>(A) Density and overlay dot plots of memory subsets in total (density) and HIV-specific CD8<sup>+...
Abstract Background CD8+ T cells may play an important role in protecting against HIV. However, the ...
<p>The percentage of <i>naïve</i> CD4+ T cells (CD45RA+CCR7+) (A), <i>central memory</i> (CD45RA−CCR...
<p>ASCT recipients and HIV-infected patients displayed similar ratios between CD4+ subpopulations, C...
Reduced CD4 T lymphocytes counts can be observed in HIV infection and in patients undergoing autolog...
BACKGROUND: Although effective antiretroviral therapy(ART) increases CD4+ T-cell count, responses to...
Although effective antiretroviral therapy(ART) increases CD4+ T-cell count, responses to ART vary co...
Background: Although effective antiretroviral therapy(ART) increases CD4+ T-cell count, responses to...
<p>(<b>A</b>) Representative flow cytometric plots of CCR7 versus CD45RO from a pre- (day -159) and ...
Several studies have identified main changes in T- and B-lymphocyte subsets during chronic HIV infec...
Background: Repeated exposure to HIV is not always associated with infection and multiple cohorts of...
<p>ASCT recipients displayed significantly higher levels of TNF-α and IFN-γ producing CD8+ T cells u...
<p>Frequencies of naïve (N, CD28<sup>Int</sup>CD95<sup>Lo</sup>CD45RA<sup>Hi</sup>CCR7<sup>Hi</sup>)...
<p>Based on the lineage markers, CD45RA and CCR7 bulk CD8+ T cells of HIV-1 Controllers (black bars)...
BACKGROUND: Reduced CD4 T lymphocytes counts can be observed in HIV infection and in patients underg...
<p>(A) Density and overlay dot plots of memory subsets in total (density) and HIV-specific CD8<sup>+...
Abstract Background CD8+ T cells may play an important role in protecting against HIV. However, the ...
<p>The percentage of <i>naïve</i> CD4+ T cells (CD45RA+CCR7+) (A), <i>central memory</i> (CD45RA−CCR...
<p>ASCT recipients and HIV-infected patients displayed similar ratios between CD4+ subpopulations, C...
Reduced CD4 T lymphocytes counts can be observed in HIV infection and in patients undergoing autolog...
BACKGROUND: Although effective antiretroviral therapy(ART) increases CD4+ T-cell count, responses to...
Although effective antiretroviral therapy(ART) increases CD4+ T-cell count, responses to ART vary co...
Background: Although effective antiretroviral therapy(ART) increases CD4+ T-cell count, responses to...
<p>(<b>A</b>) Representative flow cytometric plots of CCR7 versus CD45RO from a pre- (day -159) and ...
Several studies have identified main changes in T- and B-lymphocyte subsets during chronic HIV infec...
Background: Repeated exposure to HIV is not always associated with infection and multiple cohorts of...
<p>ASCT recipients displayed significantly higher levels of TNF-α and IFN-γ producing CD8+ T cells u...
<p>Frequencies of naïve (N, CD28<sup>Int</sup>CD95<sup>Lo</sup>CD45RA<sup>Hi</sup>CCR7<sup>Hi</sup>)...
<p>Based on the lineage markers, CD45RA and CCR7 bulk CD8+ T cells of HIV-1 Controllers (black bars)...
BACKGROUND: Reduced CD4 T lymphocytes counts can be observed in HIV infection and in patients underg...
<p>(A) Density and overlay dot plots of memory subsets in total (density) and HIV-specific CD8<sup>+...
Abstract Background CD8+ T cells may play an important role in protecting against HIV. However, the ...